Evidence map›Paper›PMID 42048987›Full record

ArticleAtencion primaria2026

[Pharmacological prescription: inhalers and antimicrobials].

Isabel Barrio Díez, Anna M Rodríguez Ferré

Abstract readEnglish Abstract
In one paragraph

Article in Atencion primaria, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Isabel Barrio DíezMedicina Familiar y Comunitaria. CS Sárdoma. Miembro del Programa Salud Planetaria de la semFYC. Miembro del GdT Utilización de fármacos de semFYC, Vigo, España. Electronic address: isabelbarriodiez@gmail.com.
Anna M Rodríguez FerréMedicina Familiar y Comunitaria. ABS Sta Eugènia de Berga. Miembro del Programa Salud Planetaria de la semFYC. Miembro del GdT de Salut Planetària de CAMFiC, Barcelona, España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The healthcare sector contributes to the carbon footprint. It is believed that it could account for 4-5% of global net emissions. Part of these emissions correspond to the pharmaceutical sector. In primary care, family doctors are in a privileged position, accessible and close to their patients, to prescribe rationally, based on scientific evidence, taking into account environmental health and, above all, consulting with the patient. Thus, when prescribing inhalers for respiratory therapy, bearing in mind that pMDIs have a more powerful greenhouse effect than CO2, alternatives should be sought whenever possible. And when prescribing antibiotics, to reduce the impact of resistance and its ecological consequences. It is urgent to minimise the environmental impact of our prescribing in order to reduce our carbon footprint, respecting, preserving and committing to the health of our planet.

Indexed as

Anti-Infective AgentsDrug PrescriptionsNebulizers and VaporizersCarbon FootprintHumansAnti-Infective AgentsAntibiotic resistanceCarbon footprint in the healthcare sectorHuella de carbono sector sanitarioInhaladores presurizadosPressurised inhalersRacionalizar prescripciónRationalising prescriptionsResistencia antibiótica

Identifiers

PMID42048987
PMCPMC13138188

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.